The molecular pharmacology of estrogen receptor modulators: Implications for the treatment of breast cancer

Donald P. McDonnell, Douglas Yee, Richard Santen, Kent Osborne, Angela Brodie

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Abstract

In addition to physiologic activities in the reproductive, skeletal, and central nervous systems, estrogens have been shown to play important roles in the aberrant cell proliferation observed in breast and reproductive tract cancers. Not surprisingly, pharmaceuticals that target different steps in the estrogen signal transduction pathway have found widespread use in the treatment of a wide variety of estrogen-linked disorders. The goal of this review is to outline what is known about the molecular pharmacology of the estrogen receptor and discuss how this information can be used to guide selection of drugs for a particular therapeutic application, and identify new targets where pharmaceutical exploitation could yield novel therapeutics.

Original languageEnglish (US)
Pages (from-to)871s-877s
JournalClinical Cancer Research
Volume11
Issue number2 II
StatePublished - Jan 15 2005

Fingerprint Dive into the research topics of 'The molecular pharmacology of estrogen receptor modulators: Implications for the treatment of breast cancer'. Together they form a unique fingerprint.

Cite this